Financhill
Back

Protagonist Therapeutics Vs. Precision BioSciences Industry Stock Comparison

Sell
32

PTGX
Protagonist Therapeutics

Last Price:
42.64
Seasonality Move:
12.96%
Sell
28

DTIL
Precision BioSciences

Last Price:
8.07
Seasonality Move:
-6.51%
Sell
32
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $43.19. The Score for PTGX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Precision BioSciences (DTIL) is a Sell

Is Precision BioSciences a Buy, Sell or Hold?

  • The current Precision BioSciences [DTIL] share price is $8.40. The Score for DTIL is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • DTIL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $43.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

DTIL Stock Price Chart

What is Precision BioSciences's stock price today?

  • The Precision BioSciences share price today is $8.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: -566040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.97 - 47.71) Sell
Bollinger Bands (100): (36.87 - 46.33) Buy

DTIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 43.2 Sell
Chaikin Money Flow: 200773 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.33 - 8.93) Sell
Bollinger Bands (100): (8.7 - 10) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.32 Sell
20-day SMA: 46.77 Sell
50-day SMA: 45.53 Sell
200-day SMA: 35.17 Buy
8-day EMA: 45.98 Sell
20-day EMA: 46.24 Sell
50-day EMA: 44.92 Sell
200-day EMA: 36.49 Buy

DTIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.47 Sell
20-day SMA: 8.54 Sell
50-day SMA: 9.16 Sell
200-day SMA: 10.78 Sell
8-day EMA: 8.43 Sell
20-day EMA: 8.58 Sell
50-day EMA: 8.98 Sell
200-day EMA: 11.17 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Precision BioSciences Earnings Growth & DTIL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.23 per share, and a decrease next year of $9.65 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Precision BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):